REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 2 filers reported holding REGULUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | 0.0% | 6,927 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 6,927 | +198.6% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 2,320 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -50.0% | 2,320 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | -94.1% | 2,320 | -95.3% | 0.00% | – |
| Q4 2020 | $68,000 | +100.0% | 49,788 | -23.2% | 0.00% | – |
| Q3 2020 | $34,000 | -22.7% | 64,811 | 0.0% | 0.00% | – |
| Q2 2020 | $44,000 | +91.3% | 64,811 | +32.8% | 0.00% | – |
| Q1 2020 | $23,000 | -46.5% | 48,817 | 0.0% | 0.00% | – |
| Q4 2019 | $43,000 | +22.9% | 48,817 | 0.0% | 0.00% | – |
| Q3 2019 | $35,000 | -42.6% | 48,817 | 0.0% | 0.00% | – |
| Q2 2019 | $61,000 | +22.0% | 48,817 | 0.0% | 0.00% | – |
| Q1 2019 | $50,000 | +11.1% | 48,817 | 0.0% | 0.00% | – |
| Q4 2018 | $45,000 | – | 48,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,401,491 | $968,000 | 0.58% |
| Endurant Capital Management LP | 3,547,208 | $2,450,000 | 0.56% |
| Sarissa Capital Management LP | 1,851,851 | $1,279,000 | 0.10% |
| Ikarian Capital, LLC | 1,228,416 | $849,000 | 0.06% |
| NEA Management Company, LLC | 6,451,056 | $4,455,000 | 0.05% |
| GYL FINANCIAL SYNERGIES, LLC | 41,000 | $28,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 64,708 | $45,000 | 0.01% |
| All Terrain Financial Advisors, LLC | 15,000 | $10,000 | 0.00% |
| WealthTrust Axiom LLC | 13,000 | $8,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 2,227,212 | $1,538,000 | 0.00% |